Optimal Duration of antiplatelet Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

Optimal Duration of antiplatelet Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events : BVS-LATE trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002908

Enrollment

2000

Registered

2018-06-02

Start date

2017-03-09

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Clopidotrel monotherapy : On patients with no event between 12months and 14months from Bioresorbable Vascular Scaffold implantation, apply clopidogrel monotherapy

stop aspirin vs. Dual antiplatelet therapy : On patients with no event between 12months and 14months from Bioresorbable Vascular Scaffold implantation, apply dual antiplatelet therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 19 and more On dual or triple antiplatelet therapy and between 12months and 14months from Bioresorbable Vascular Scaffold implantation No history of death, serious myocardial infarction, stroke, repeat revascularization, or major bleeding

Exclusion criteria

Exclusion criteria: Contraindication to antiplatelet therapy Need to continue clopidogrel due to stroke, peripheral disease, significant carotid disease or recent acute coronary syndrome Major bleeding history or bleeding diathesis Life expentancy less than 1year due to non-cardiac disease Pregnancy

Design outcomes

Primary

Measure	Time frame
Composite event of death, myocardial infarction, or stroke	—

Secondary

Measure	Time frame
Stroke;Myocardial infarction;Target Lesion Revascularization;Stent thrombosis;Bleeding;Target Vessel Revascularization	—

Countries

Korea, Republic of

Contacts

Public ContactSeung-jung Park

University of Ulsan

Outcome results